09.01.2020 14:41:25

ANI Pharma Acquires U.S. Portfolio Of 23 Generic Products From Amerigen

(RTTNews) - ANI Pharmaceuticals Inc. (ANIP) said that it has acquired the U.S. portfolio of 23 generic products from Amerigen Pharmaceuticals Ltd. for $52.5 million in cash at close and up to $25 million in contingent profit share payments over the next four years.

The acquired portfolio includes ten commercial products, three approved products with launches pending, four filed products and four in-development products as well as a license to commercialize two approved products.

Analysen zu Biosante Pharmaceuticals Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Biosante Pharmaceuticals Inc 54,00 -2,70% Biosante Pharmaceuticals Inc